Print Page | Close Window
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
05/16/13Gevo to Present at the Cowen Technology, Media & Telecommunications Conference
ENGLEWOOD, Colo., May 16, 2013 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) announced today that Gevo's executive vice president and general counsel Brett Lund and chief financial officer Mark Smith will participate in a renewable biomaterials panel discussion at the Cowen and Company 41st Annual Technology, Media & Telecommunications Conference on Thursday, May 30, 2013 at 11:00 AM PDT / 2:00 PM EDT. The conference is being held at the New York Palace Hotel in New York City. About Gevo ... 
Printer Friendly Version
05/10/13Gevo Temporarily Dismisses GIFT(R) Lawsuit Because Butamax Does Not Have a Commercial Biobutanol Plant
ENGLEWOOD, Colo., May 10, 2013 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced that it has agreed to temporarily dismiss its lawsuit against Butamax Advanced Biofuels, LLC (Butamax) and E. I. du Pont de Nemours and Company (DuPont) for infringing one of Gevo's three GIFT® patents, US Patent No. 8,101,808 ( '808 Patent). Gevo maintains all of its other lawsuits against Butamax and DuPont for infringing Gevo's biocatalyst technology. "When we filed this lawsuit, we expected Butama... 
Printer Friendly Version
04/30/13Gevo Awarded Foundational Patent for Commercially Viable Isobutanol Production
ENGLEWOOD, Colo., April 30, 2013 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) announced today that it has been issued a new patent, U.S. Patent No. 8,431,374 ('374 Patent), covering the foundational methods for low-cost isobutanol production at commercially relevant titer, productivity, and yields. "This is a milestone achievement toward our goal of making commercial isobutanol a reality," said Brett Lund, Gevo's executive vice president and general counsel. "Titer, productivity, and yield a... 
Printer Friendly Version
04/30/13Gevo Reports First Quarter 2013 Financial Results
Reports EPS of ($0.45) including $1.3 million non-cash loss from the change in fair value of embedded derivatives contained in Gevo's convertible notes Ended the quarter with cash and cash equivalents of $54 million Net cash used of $12.6 million in first quarter of 2013 compared to net cash used of $25.3 million in fourth quarter of 2012 Maintains expectation to begin to produce isobutanol in 2013 at Luverne, Minn. plant U.S. District Court for the District of Delaware e... 
Printer Friendly Version
04/16/13Gevo to Host Conference Call to Report First Quarter Financial Results on April 30, 2013
ENGLEWOOD, Colo. – April 16, 2013 – Gevo, Inc. (NASDAQ: GEVO) today announced that the company will host a conference call on Tuesday, April 30, 2013 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the first quarter ended March 31, 2013 and provide an update on recent corporate highlights. To participate in the conference call, please dial 1-877-280-4956 (inside the US) or 1-857-244-7313 (outside the US) and reference the access code 47611875. The presentation will be avail... 
Printer Friendly Version
04/11/13District Court Issues Final Judgment for Gevo
Court enters judgment that Gevo does not infringe ENGLEWOOD, Colo. - April 11, 2013 - Gevo, Inc. (NASDAQ: GEVO) announced today that the United States District Court for the District of Delaware entered a final judgment in favor of Gevo and against Butamax Advanced Biofuels, LLC (Butamax), a 50/50 joint venture between DuPont and BP, ending the trial court proceedings on Butamax's Patent Nos. 7,851,188 ('188 Patent) and 7,993,889 ('889 Patent). "We applaud the final judgment, which allow... 
Printer Friendly Version
04/11/13Gevo Overcomes 110 Rejections in USPTO Reexamination
ENGLEWOOD, Colo. - April 11, 2013 - Gevo, Inc. (NASDAQ: GEVO) announced today that the U.S. Patent and Trade Office (USPTO) issued a second office action in the ongoing inter partes reexamination of Gevo's U.S. Patent No. 8,101,808 ('808 Patent) entitled "Recovery of Higher Alcohols from Dilute Aqueous Solutions", which relates to Gevo's Integrated Fermentation Technology® (GIFT®). The Examiner's decision, which dismissed 110 previous grounds of rejection and introduced a limited numbe... 
Printer Friendly Version
03/22/13Brett Lund Named Top Forty Business Leader Under 40 by The Denver Business Journal
ENGLEWOOD, Colo. - March 22, 2013 - Gevo, Inc. (NASDAQ: GEVO) is pleased to announce Executive Vice President and General Counsel Brett Lund has been named one of the Top Forty Business Leaders Under 40 Years Old by the Denver Business Journal.  Mr. Lund was recognized for his business success and community contributions. "I congratulate Brett on this award.  I am pleased that the Denver Community recognizes Brett and his achievements," said Dr. Patrick Gruber, Gevo's Chief Executiv... 
Printer Friendly Version
03/21/13Gevo Wins Patent Suit in Delaware Court
Butamax admits Gevo does not infringe and trial not needed ENGLEWOOD, Colo. - March 21, 2013 - Gevo, Inc. (NASDAQ: GEVO), announced today that a judgment of non-infringement will be entered for Gevo following the acknowledgment by Butamax Advanced Biofuels LLC (Butamax) that Gevo does not infringe Butamax's asserted patents under the Court's construction of a key claim term in Butamax's Patent Nos. 7,851,188 and 7,993,889.  As a result of this victory, a judgment of non-infringement will... 
Printer Friendly Version
03/19/13Gevo Announces a Strategic Hire for its Executive Team
Reports an Equity Grant Under NASDAQ Listing Rule 5635(c)(4) ENGLEWOOD, Colo. - March 19, 2013 - Gevo, Inc. (NASDAQ: GEVO) today announced that it has expanded its executive team to include Dr. Stephen P. Toon as its Executive Vice President of Operations and Process Development. In his new role at Gevo, Dr. Toon will report to Christopher Ryan, Ph.D., President, Chief Operating Officer, and Chief Technology Officer, and will have overall responsibility for Gevo's Luverne, Minn. facility from... 
Printer Friendly Version
03/05/13Gevo Reports Fourth Quarter 2012 Financial Results
Reports EPS of ($0.34) including $2 million non-cash gain from the change in fair value of embedded derivatives contained in Gevo's convertible notes  Ended the year with cash and cash equivalents of $67 million  Reiterates expectation to produce isobutanol in 2013  Luverne, Minn. plant remains temporarily idle while being readied to restart after completion of process technology optimization  U.S. Court of Appeals for the Federal Circuit affirmed District Court's favorable decision ... 
Printer Friendly Version
02/04/13Gevo to Host Conference Call to Report Fourth Quarter and Year-End 2012 Financial Results on March 5, 2013
ENGLEWOOD, Colo. - February 4, 2013 - Gevo, Inc. (NASDAQ: GEVO), today announced that the company will host a conference call on Tuesday, March 5, 2013 at 4:30 p.m. EST (2:30 p.m. MST) to report its financial results for the fourth quarter ended Dec. 31, 2012 and provide an update on recent corporate highlights. To participate in the conference call, please dial 1-800-265-0241 (inside the US) or 1-617-847-8704 (outside the US) and reference the access code 53437085. The presentation will be ava... 
Printer Friendly Version
01/17/13Mark Udall, United States Senator for Colorado, Visits Gevo, Advocates Alternative Energy Solutions
ENGLEWOOD, Colo. - January 17, 2013 - Unites States Senator Mark Udall of Colorado toured and met with Gevo, Inc. (NASDAQ: GEVO) yesterday to discuss the importance of alternative energy technologies for Colorado and the U.S. economy. Senator Udall met with Chief Executive Officer Patrick Gruber, Ph.D. to discuss renewable energy options and see first-hand the innovative research and development Gevo has done that will enable it to be a leading provider of renewable chemicals and biofuels.  ... 
Printer Friendly Version
01/02/13Gevo Announces Stock Repurchase Program
ENGLEWOOD, Colo. - January 2, 2013 - Gevo, Inc. (NASDAQ: GEVO) today announced that its Board of Directors has approved a stock repurchase program that authorizes Gevo to repurchase up to $15,000,000 of its common stock over a one-year period. The Company expects to fund its stock repurchase program with existing cash and cash equivalents on hand. Any shares repurchased will be classified as treasury stock or retired. "This new stock repurchase program reflects our confidence in Gevo's future... 
Printer Friendly Version